Venous thromboembolism in cancer patients referred to the American University of Beirut - Medical Center secondary to deep vein thrombosis; occurrence and risk factors

Journal of Thrombosis and Thrombolysis

Volumn 20, Issue 3, 2005, Pages 179-182

  Sleiman, Wissam H ^a   Asfahani, Zade ^a   Taher, Ali T ^a   Al Rahawi, Denize ^a   Khalil, Ismail ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Cancer; Deep vein thrombosis; Prophylaxis; Risk factors

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; BRAIN CANCER; CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COLON CANCER; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; LEBANON; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; OBESITY; OVARY CANCER; PANCREAS CANCER; PATIENT REFERRAL; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UTERINE CERVIX CANCER;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 27944454831     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-005-4048-9     Document Type: Article

References (23)

1. Trousseau A. Phlegmasia alba dolens: In clinique medicale de L'Hotele-Dieu de Paris, ed 2. Paris, Balliere, 1865;3:654-712.
2. Gouin-Tibault I, Achkar A, Samama MM. The thrombopilitic state in cancer patients. Acta Haematol 2001;106:33-42. 10.1159/000046587
3. Kakkar VV, Howe CT, Nicolaides AN, Renney JTD, Clarke MB. Deep vein thrombosis of the leg. Is there a high-risk group? Am J Surg 1970;120:527-530 4097038
4. Hills NH, Pflugg JJ, Jeyasingh K, Boardman L, Calnam JS. Prevention of deep vein thrombosis by intermittent pneumatic compression of the calf. British Medical Journal 1972;1:131-135. 5007837
5. Rosenberg IL, Evans M, Pollock AV, Prophylaxis of postoperative leg vein thrombosis by low dose subcutaneous heparin or preoperative calf muscle stimulation: A controlled clinical trial. Br Med J 1975;i:649-651.
6. Sue-ling HM, Johnson D, McMahon MV, Philips PR, Davies JA. Preoperative identification of patients at high risk of Deep vein thrombosis after elective major abdominal surgery. Lancet 1986;i:649-651.
7. Gale A, Gordon S. Update on tumor cell procoagulant factors. Acta Haematol 2001;106:25-32. 10.1159/000046586
8. Green KB, Silverstein RL. Hypercoagulability in cancer. Hematol Oncol Clin North Am 1996;10:499-530. 10.1016/S0889-8588(05)70349-X
9. Thodiyil PA, Walsh DC, Kakkar AK. Thromboprophylaxis in the cancer patient. Acta Haematol 2001;106:73-80. 10.1159/000046592
10. Carmeliet P, Collen D. Tissue factor. Int J Biochem Cell Biol 1998;30:661-667 10.1016/S1357-2725(97)00121-0
11. Falanga A, Gordon SG. Isolation and characterization of cancer procoagulant: A cysteine proteinase from malignant tissue. Biochemistry 1985;24:5558-5567. 10.1021/bi00341a041
12. Gordon SG, Cross BA. A factor X-activating cysteine protease from malignant tissue. J Clin Invest 1981;67:1665-1671. 7016920
13. Olas B, Wachowicz B, Mielicki WP, Buczynski A. Free radicals are involved in cancer procoagulant-induced platelet activation. Thromb Res 2000;97:169-175. 10.1016/S0049-3848(99)00129-2
14. Olas B, Mielicki WP, Wachowicz B, Krajewski T. Cancer procoagulant stimulates platelets adhesion. Thromb Res 1999;94:199-203. 10.1016/ S0049-3848(98)00214-X
15. Michael J. R. Edmonds, Timothy J. H. Crichton, William B. Runciman, Malcolm Pradhan. Evidence-based risk factors for postoperative deep vein thrombosis. ANZ Journal of Surgery 2004;74:1082 10.1111/ j.1445-1433.2004.03258.x
16. Sorensen H, Mellemakjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep veinous thrombosis or pulmonary embolism. N Eng J Med 1998;338:1169-1173. 10.1056/ NEJM199804233381701
17. Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M. Venous Thromboembolism and cancer. Lancet 1998;351:1077-1080. 10.1016/ S0140-6736(97)10018-6
18. Ali Shamseddine A, Sibai A, Gehchan N, et al. Cancer incidence in postwar Lebanon: Findings from the first national population-based registry, 1998. Annals of Epidemiology 2004;14(9):663-668. 10.1016/ j.annepidem.2003.12.002
19. Falanga A, Rickles FR. Pathophysiology of the thrombophilic state in cancer patients. Semin Thromb Hemost 1999;25:173-182. 10357085
20. Thodiyil PA, Walsh DC, Kakkar AK. Thromboprophylaxis in the cancer patient. Acta Haematol 2001;106:73-80. 10.1159/000046592
21. Yap K, McCready D. Deep vein thrombosis and malignancy: A surgical oncologist's perspective. Asian J Surg 2004;27(3):249-254. 15564173
22. Pritchard KI, Paterson AH, Paul NA, Zee B, Fine S, Pater J. Increased thromboembolic complications with concurrent tamoxiphen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group. J Clin Oncol 1996;14:2731-2737. 8874334
23. William H. G, Graham F. P, John A. H, et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3S):338S-400S.